ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Lantern Pharma Inc

Lantern Pharma Inc (LTRN)

3,49
-0,17
(-4,64%)
Beim Schlusskurs: 11 März 9:00PM
3,49
0,00
( 0,00% )
Nach Börsenschluss: 11:39PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
3,49
Gebot
3,40
Fragen
4,00
Volumen
43.425
3,43 Tagesbereich 3,76
2,79 52-Wochen-Bereich 11,99
Marktkapitalisierung
Handelsende
3,66
Handelsbeginn
3,60
Letzte Trade
17
@
3.43
Letzter Handelszeitpunkt
23:20:40
Finanzvolumen
US$ 154.414
VWAP
3,5559
Durchschnittliches Volumen (3 Mio.)
100.449
Ausgegebene Aktien
10.784.725
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,33
Gewinn pro Aktie (EPS)
-1,48
Erlöse
-
Nettogewinn
-15,96M

Über Lantern Pharma Inc

Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence (A.I), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline o... Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence (A.I), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline of development programs involves four drug candidates and an Antibody Drug Conjugate (ADC) program directed towards eight therapeutic targets. Its A.I. platform, known as RADR, includes more than 18 billion data points, and uses big data analytics and machine learning to rapidly uncover biologically relevant genomic signatures correlated to drug response, and then identify the cancer patients that we believe may benefit most from our compounds. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Lantern Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LTRN. The last closing price for Lantern Pharma was US$3,66. Over the last year, Lantern Pharma shares have traded in a share price range of US$ 2,79 to US$ 11,99.

Lantern Pharma currently has 10.784.725 shares in issue. The market capitalisation of Lantern Pharma is US$39,47 million. Lantern Pharma has a price to earnings ratio (PE ratio) of -2.33.

LTRN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.35-9.114583333333.8443.45419733.8019011CS
4-1.77-33.65019011415.265.263.45577324.41789709CS
120.133.869047619053.366.1182.951004494.5305397CS
26003.496.1182.79742124.13541336CS
52-4.61-56.91358024698.111.992.791143756.07491383CS
156-2.97-45.97523219816.4611.992.38706685.71576577CS
260-11.67-76.978891820615.1624.842.38763579.22434469CS

LTRN - Frequently Asked Questions (FAQ)

What is the current Lantern Pharma share price?
The current share price of Lantern Pharma is US$ 3,49
How many Lantern Pharma shares are in issue?
Lantern Pharma has 10.784.725 shares in issue
What is the market cap of Lantern Pharma?
The market capitalisation of Lantern Pharma is USD 39,47M
What is the 1 year trading range for Lantern Pharma share price?
Lantern Pharma has traded in the range of US$ 2,79 to US$ 11,99 during the past year
What is the PE ratio of Lantern Pharma?
The price to earnings ratio of Lantern Pharma is -2,33
What is the reporting currency for Lantern Pharma?
Lantern Pharma reports financial results in USD
What is the latest annual profit for Lantern Pharma?
The latest annual profit of Lantern Pharma is USD -15,96M
What is the registered address of Lantern Pharma?
The registered address for Lantern Pharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Which industry sector does Lantern Pharma operate in?
Lantern Pharma operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CUTRCutera Inc
US$ 0,2051
(59,61%)
31,57M
TNONTenon Medical Inc
US$ 1,81
(44,80%)
3,91M
SNOASonoma Pharmaceuticals Inc
US$ 3,6199
(29,75%)
4,14M
LFMDLifeMD Inc
US$ 5,33
(24,82%)
331,05k
BKYIBIO key International Inc
US$ 1,35
(22,73%)
1,28M
STSSSharps Technology Inc
US$ 0,3549
(-19,34%)
6,45M
LZMHLZ Technology Holdings Ltd
US$ 13,25
(-15,39%)
16,14k
HSAIHesai Group
US$ 13,75
(-14,12%)
344,05k
PPIAxs Astoria Inflation Sensitive ETF
US$ 12,04
(-14,06%)
179
LDTCLeddarTech Holdings Inc
US$ 0,4801
(-12,55%)
1,48k
CUTRCutera Inc
US$ 0,2051
(59,61%)
31,57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7,03
(-4,74%)
12,61M
SYRSSyros Pharmaceuticals Inc
US$ 0,102
(11,35%)
8,93M
NVDANVIDIA Corporation
US$ 105,10
(-1,76%)
7M
TSLATesla Inc
US$ 216,8499
(-2,39%)
6,65M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock